Lynx and Solexa Buy DNA Cluster Technology from Manteia | GenomeWeb

NEW YORK, March 25 (GenomeWeb News) - Lynx Therapeutics and Solexa have acquired technology for generating DNA colonies from Manteia, the companies said today.

 

The technology, from Swiss-based Manteia, generates millions of DNA fragments from a single DNA molecule to create DNA colonies, or clusters on a surface.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.